The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Spain; Roche; Takeda
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Inivata; Stilla Technologies
Travel, Accommodations, Expenses - AstraZeneca; Roche; Takeda
Prediction of brain metastases progression and overall survival in patients with metastatic non-small cell lung cancer treated by immune checkpoint inhibitors using a radiomic model.
 
Clemence Henon
No Relationships to Disclose
 
Lizza Hendriks
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech; Roche/Genentech (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
Speakers' Bureau - AstraZeneca (Inst); Bayer (Inst); Benecke; high5oncology (Inst); Lilly (Inst); Medtalks; MSD (Inst); Takeda (Inst); VJOncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Other Relationship - Abbvie (Inst); AstraZeneca; AstraZeneca (Inst); BluPrint Oncology (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck Serono (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Alexandre Carré
No Relationships to Disclose
 
Laura Mezquita
No Relationships to Disclose
 
Sylvain Reuzé
No Relationships to Disclose
 
Samy Ammari
No Relationships to Disclose
 
Mihaela Aldea
Consulting or Advisory Role - Viatris
Travel, Accommodations, Expenses - Sandoz
 
Charlotte Robert
No Relationships to Disclose
 
Cecile Le Pechoux
Honoraria - Medscape (Inst); Prime Oncology
Consulting or Advisory Role - AstraZeneca (Inst); Bristol Myers Squib; Roche (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Clarisse Audigier-Valette
No Relationships to Disclose
 
Julien Mazieres
No Relationships to Disclose
 
Corentin Lefebvre
No Relationships to Disclose
 
Audrey Rabeau
No Relationships to Disclose
 
Boris Duchemann
No Relationships to Disclose
 
Angela Botticella
No Relationships to Disclose
 
David Planchard
No Relationships to Disclose
 
Eric Deutsch
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Genzyme (Inst); Genzyme (Inst); Hedera Dx (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst); socar (Inst); Taiho Pharmaceutical (Inst); Turning Point Therapeutics (Inst)
 
Roger Sun
No Relationships to Disclose